About
AKUOS is a biotechnology company based in Boston, Massachusetts, focused on precision genetic medicine for hearing disorders. Founded in 2016, the company develops gene therapies aimed at restoring and preserving high-acuity hearing for individuals with disabling hearing loss. Their innovative approach utilizes a proprietary adeno-associated viral (AAV) vector library and advanced delivery methods to target sensorineural hearing loss. The core mission of AKUOS is to enhance the inner ear's ability to produce essential proteins for hearing and to rejuvenate critical structures involved in sound processing. Their therapies are designed to protect against hearing loss caused by various factors, including drug exposure, noise, and aging. AKUOS aims to provide effective treatments for genetic forms of hearing loss that currently lack options, benefiting patients worldwide.
Technologies
Keywords
Company Information
-
Employees 10
-
Founded 2017
-
Total Funding $500000
Location
114 Lavender St, Singapore, Singapore, 338729